Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$4.84 - $12.38
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | $289.30M |
EV | $156.97M |
Shares Outstanding | 50.23M |
Beta | 0.43 |
Analyst Rating | BUY |
Analyst Target Price | $22.00 |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | - |
EPS | -3.40% |
Operating Cash Flow | -35.00% |
Free Cash Flow | -32.90% |
Revenue | - |
EPS | -11.90% |
Operating Cash Flow | -19.30% |
Free Cash Flow | -23.60% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -46.01% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Aura Biosciences, Inc.
AURA
Sector
Healthcare
Industry
Biotechnology
CEO
de los Pinos, Elisabet
Employees
108
Website
www.aurabiosciences.comIPO Date
2021-10-29
Headquarters
80 Guest Street, 5th Floor, Boston, Massachusetts, 02135, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved